Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein

Author： Sennels H. P.   Jacobsen S.   Jensen T.   Hansen M. S.   Østergaard M.   Nielsen H. J.   Sørensen S.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.67, Iss.8, 2007-01, pp. : 821-835

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?

By Wagner Doris  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 17-18, 2010-09 ,pp. : 452-457

Springer Publishing Company

Access to resources Recommend Favorite

Implications of Measuring Soluble Receptor Activators of Nuclear Factor-κB Ligand and Osteoprotegerin in Bone Metabolism of Elderly Women

By  

Gerontology, Vol. 55, Iss. 3, 2009-01 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

By Kananen K.   Volin L.   Laitinen K.   Ruutu T.   Välimäki M.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 724-730

Springer Publishing Company

Access to resources Recommend Favorite

Serum High-Sensitivity C-Reactive Protein Is Not Increased in Patients with IgA Nephropathy

By  

Nephron Clin Pract, Vol. 108, Iss. 1, 2007-12 ,pp. : c35-c40

Karger

Access to resources Recommend Favorite

Variability of High-Sensitivity C-Reactive Protein in Chronic Heart Failure

By  

Cardiology, Vol. 113, Iss. 3, 2009-01 ,pp. : 180-183

Karger

Access to resources Recommend Favorite